welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- login
completed
Research of Biomarkers in Duchenne Muscular Dystrophy Patients
study id #: NCT01380964
condition: Duchenne Muscular Dystrophy (DMD)
status: completed
purpose:The purpose of this study is to identify potential biomarkers for the diagnosis, disease progression assessment and response to treatment in patients with Duchenne Muscular Dystrophy.
mechanism of action: No pharmaceutical intervention
results: https://clinicaltrials.gov/ct2/show/results/NCT01380964
last updated: November 21, 2018
study details
study contacts
rareRelated
-
Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD)The purpose of this study is to establis...
-
Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular DystrophyThe aim of this multicentre, prospective...
-
Whole Body Vibration Therapy in Boys With Duchenne Muscular DystrophyWhole-body vibration therapy (WBVT) is a...
-
Clinical trial shows some promise for Duchenne muscular dystrophy drugThe results of an international clinical...
-
Study of Ataluren in >=2 to <5 Year-Old Males With Duchenne Muscular DystrophyThis is a Phase 2, multiple-dose, open-l...
-
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular DystrophyThe primary objective of this study is t...
-
Study of Eteplirsen in DMD PatientsThe main objective of this study is to p...
-
First Duchenne Drug Approved by the FDAhttps://www.youtube.com/watch?v=xQWfXKL1...
-
State-of-the-art advances in Duchenne muscular dystrophyDuchenne muscular dystrophy (DMD) is a s...
-
Shape Therapeutics’s RNA Editing Gene Therapy Platform Focused on Curing Genetic DiseasesShape Therapeutics, Inc. (ShapeTx), a de...
-
Rare diseases require unique approaches in clinical trial designThere are 7,000 known rare diseases and ...
